The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

U.S. Rep. Rosa DeLauro, D-3 and Federal Trade Commission Chair Lina Khan met in New Haven to hear about the challenges facing ...

They’re competing unfairly with Medicare, and you and I are paying for it. It’s obscene. When George W. Bush and ...

The Senate will advance a bipartisan stopgap government funding bill on Thursday after efforts to pass a similar measure in ...

Using money from Stormont’s financial transactions capital (FTC) funding pot, the NIIF operates as a private sector entity managed by CBRE, providing debt funding for ‘commercial property ...

This story has been updated with a statement from Kroger. The Federal Trade Commission (FTC) has reached the halfway point in ...

The FTC under Khan has become more aggressive in ... Their valuations will in turn be lower, and fewer of them will get funding in the first place, because VCs will be less confident of a big ...

But outside experts called Candeub's ideas for the Federal Trade Commission a "bold vision ... moving education funding and decisions to the states and banning transgender women from competing ...

Benefits Pro: Employers Need To Stop Maximizing PBM Drug Plan Rebates, Says Mark Cuban Cuban, the founder of the Mark Cuban Cost Plus Drug mail-order pharmacy, said the main rebate funding ...

The U.S. Federal Trade Commission will urge a federal judge in New York to block Tapestry's $8.5 billion merger with rival handbag maker Capri Holdings at a trial beginning on Monday, arguing it ...

Photo by Christian Gooden, [email protected] ST. LOUIS COUNTY — Express Scripts, Inc. sued the Federal Trade Commission on Tuesday over a report the pharmacy benefit management company ...